Aclarion, Inc. (ACONW) stock
ACONWNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as ACON
$0.02+0.00 (0.00%)
Close on Oct 30, 2026Market cap $5.62MP/E –Yield –
Aclarion operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Aclarion's operating income for the twelve months ending Jun 30, 2026 was -$9.71M. For fiscal 2025 it was -$7.05M. The highest annual figure on record is -$2.95M in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$7.05M | – |
| FY2024 | Dec 31, 2024 | -$5.51M | – |
| FY2023 | Dec 31, 2023 | -$4.88M | – |
| FY2022 | Dec 31, 2022 | -$5.56M | – |
| FY2021 | Dec 31, 2021 | -$2.95M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.90M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.99M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.99M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.83M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.74M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.49M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.81M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.30M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.14M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.28M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.13M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.16M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.41M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.18M | – |
| Q4 FY2022 | Dec 31, 2022 | -$942.46K | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.63M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.07M | – |
| Q3 FY2021 | Sep 30, 2021 | -$797.26K | – |
| Q2 FY2021 | Jun 30, 2021 | -$626.62K | – |
| Q1 FY2021 | Mar 31, 2021 | -$460.54K | – |